Sheldon L. Koenig - Mar 17, 2022 Form 4 Insider Report for Esperion Therapeutics, Inc. (ESPR)

Role
President and CEO, Director
Signature
/s/ Richard B. Bartram, by power of attorney
Stock symbol
ESPR
Transactions as of
Mar 17, 2022
Transactions value $
-$2,615
Form type
4
Date filed
3/18/2022, 04:29 PM
Previous filing
Mar 16, 2022
Next filing
Jun 9, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ESPR Common Stock Sale -$2.62K -571 -0.29% $4.58 195K Mar 17, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares were sold to satisfy tax obligation on quarterly vested shares of restricted stock units.